Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement
Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences w...
Saved in:
| Published in | International journal of infectious diseases Vol. 26; no. C; pp. 88 - 90 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Canada
Elsevier Ltd
01.09.2014
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences with treatment regimens and durations. In the case presented herein, two different treatment regimens were applied to an immunocompromised HIV-negative patient with primary skin involvement and extensive pulmonary involvement due to suspected relapse on isoniazid, ethambutol, and clarithromycin treatment. The treatment regimen was changed to azithromycin, ciprofloxacin, and pyrazinamide and the treatment duration was prolonged to a total of 24 months, with good effect. |
|---|---|
| AbstractList | Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences with treatment regimens and durations. In the case presented herein, two different treatment regimens were applied to an immunocompromised HIV-negative patient with primary skin involvement and extensive pulmonary involvement due to suspected relapse on isoniazid, ethambutol, and clarithromycin treatment. The treatment regimen was changed to azithromycin, ciprofloxacin, and pyrazinamide and the treatment duration was prolonged to a total of 24 months, with good effect. Summary Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences with treatment regimens and durations. In the case presented herein, two different treatment regimens were applied to an immunocompromised HIV-negative patient with primary skin involvement and extensive pulmonary involvement due to suspected relapse on isoniazid, ethambutol, and clarithromycin treatment. The treatment regimen was changed to azithromycin, ciprofloxacin, and pyrazinamide and the treatment duration was prolonged to a total of 24 months, with good effect. Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences with treatment regimens and durations. In the case presented herein, two different treatment regimens were applied to an immunocompromised HIV-negative patient with primary skin involvement and extensive pulmonary involvement due to suspected relapse on isoniazid, ethambutol, and clarithromycin treatment. The treatment regimen was changed to azithromycin, ciprofloxacin, and pyrazinamide and the treatment duration was prolonged to a total of 24 months, with good effect.Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and the lymph nodes have also been reported in immunocompetent individuals. The existing literature on the subject is limited as are experiences with treatment regimens and durations. In the case presented herein, two different treatment regimens were applied to an immunocompromised HIV-negative patient with primary skin involvement and extensive pulmonary involvement due to suspected relapse on isoniazid, ethambutol, and clarithromycin treatment. The treatment regimen was changed to azithromycin, ciprofloxacin, and pyrazinamide and the treatment duration was prolonged to a total of 24 months, with good effect. |
| Author | Patsche, Cecilie Blenstrup Wejse, Christian Svensson, Erik |
| Author_xml | – sequence: 1 givenname: Cecilie Blenstrup surname: Patsche fullname: Patsche, Cecilie Blenstrup email: ceciliepatsche@live.dk organization: GloHAU, Center for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark – sequence: 2 givenname: Erik surname: Svensson fullname: Svensson, Erik organization: Mycobacteriology Laboratory, Statens Serum Institut, Copenhagen, Denmark – sequence: 3 givenname: Christian surname: Wejse fullname: Wejse, Christian organization: GloHAU, Center for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25008771$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUstu1DAUtVARbQd-gAWaJZtM_UjiGCGkqrwqFXUBrC3HuSkOiT3YzqD5e26YtotKFMnStexzzn2ce0qOfPBAyEtGN4yy-mzYuMF1G05ZuaEcD31CTlgjm0JUjB3hHb8KJRk_JqcpDZTSsq6bZ-SYV5Q2UrITcv3epQST8yZDt_6yt6E1NkN087S2MJqMsXMJTIL1b5d_rLcxjMHfIHg7j1PwJu7Xzu_CuIMJfH5OnvZmTPDiNq7I948fvl18Lq6uP11enF8VtpI8F0pRxVjPuroCUSrZG2EFGGGqljPZQENbqUQlVd83xjKsuhRUylpBq0QvQazI5UG3C2bQ2-gmLEQH4_TfhxBvtInZ2RF0S0vWGY4kRUtM13CjRA1Sdp0VLWtR6_VBC3v7NUPKenIJmx-NhzAnzaqaUVFxrGhFXt1C53aC7j7x3UARwA8AG0NKEfp7CKN6cU0PenFNL65pyvFQJDUPSNZlk13wORo3Pk59e6ACDnvnIOpkHXgLnYtgM07DPU5_94BuR-edNeNP2EMawhw92qiZTkjQX5eNWhaKlShSKYECb_4t8L_sfwBOC9o5 |
| CitedBy_id | crossref_primary_10_1016_j_rmcr_2019_100903 crossref_primary_10_1128_microbiolspec_TNMI7_0012_2016 crossref_primary_10_1186_s12879_025_10602_5 crossref_primary_10_1016_j_idcr_2018_01_015 |
| Cites_doi | 10.1080/00365540500444652 10.1183/09031936.00073611 10.2169/internalmedicine.51.7848 10.1099/00207713-43-3-539 10.1093/clinids/24.2.144 10.3349/ymj.2010.51.6.980 10.1016/j.diagmicrobio.2003.12.006 10.1016/j.ijid.2008.12.014 |
| ContentType | Journal Article |
| Copyright | 2014 The Authors The Authors Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| Copyright_xml | – notice: 2014 The Authors – notice: The Authors – notice: Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
| DOI | 10.1016/j.ijid.2014.02.020 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1878-3511 |
| EndPage | 90 |
| ExternalDocumentID | oai_doaj_org_article_b041da27e39045e382a936e77ddc3b1b 25008771 10_1016_j_ijid_2014_02_020 S1201971214014593 1_s2_0_S1201971214014593 |
| Genre | Journal Article Case Reports |
| GroupedDBID | --- --K .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 8C1 8FI 8FJ 8FQ 8R4 8R5 AAEDW AAFWJ AAIKJ AALRI AAQFI AAQXK AARKO AAXUO AAYWO ABBQC ABFRF ABMAC ABUWG ABWVN ACGFO ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFKRA AFPKN AFPUW AFRHN AFTJW AGEKW AGHFR AGQPQ AGYEJ AHMBA AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BCNDV BENPR BPHCQ BR6 BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU FYUFA G-Q GBLVA GROUPED_DOAJ GX1 HMCUK HVGLF HZ~ IHE IXB J1W KQ8 M1P M3C M3G M41 MO0 N9A O-L O9- OD- OK1 OO. OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 QTD R2- ROL RPZ RWL RXW SDF SDG SEL SES SEW SSZ TAE UKHRP UNMZH Z5R 0SF 3V. 6I. AACTN AAFTH ABVKL AFCTW ALIPV NCXOZ RIG AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c572t-990911f1d65e3497fa3c3ea3a5b2178e80b793579ff8ac16684307769eb93f7e3 |
| IEDL.DBID | DOA |
| ISSN | 1201-9712 1878-3511 |
| IngestDate | Wed Aug 27 00:18:14 EDT 2025 Fri Jul 11 16:30:07 EDT 2025 Mon Jul 21 06:04:23 EDT 2025 Tue Jul 01 04:06:53 EDT 2025 Thu Apr 24 22:59:16 EDT 2025 Fri Feb 23 02:27:32 EST 2024 Sun Feb 23 10:19:26 EST 2025 Tue Aug 26 16:31:29 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | C |
| Keywords | Non-tuberculous Mycobacterium Mycobacterium celatum |
| Language | English |
| License | http://creativecommons.org/licenses/by-nc-sa/3.0 Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c572t-990911f1d65e3497fa3c3ea3a5b2178e80b793579ff8ac16684307769eb93f7e3 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| OpenAccessLink | https://doaj.org/article/b041da27e39045e382a936e77ddc3b1b |
| PMID | 25008771 |
| PQID | 1561035279 |
| PQPubID | 23479 |
| PageCount | 3 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b041da27e39045e382a936e77ddc3b1b proquest_miscellaneous_1561035279 pubmed_primary_25008771 crossref_primary_10_1016_j_ijid_2014_02_020 crossref_citationtrail_10_1016_j_ijid_2014_02_020 elsevier_sciencedirect_doi_10_1016_j_ijid_2014_02_020 elsevier_clinicalkeyesjournals_1_s2_0_S1201971214014593 elsevier_clinicalkey_doi_10_1016_j_ijid_2014_02_020 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-09-01 |
| PublicationDateYYYYMMDD | 2014-09-01 |
| PublicationDate_xml | – month: 09 year: 2014 text: 2014-09-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Canada |
| PublicationPlace_xml | – name: Canada |
| PublicationTitle | International journal of infectious diseases |
| PublicationTitleAlternate | Int J Infect Dis |
| PublicationYear | 2014 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Piersimoni, Tortoli, De Lalla, Nista, Donato, Bornigia (bib0015) 1997; 24 Jun, Lee, Kim, Koh (bib0040) 2010; 51 Christiansen, Roberts, Patel (bib0025) 2004; 49 Ikegame, Nagamatsu, Nagata, Kazumi, Mitarai, Iwasaki (bib0035) 2012; 51 Petrini (bib0045) 2006; 38 Falzon, Jaramillo, Schünemann, Arentz, Bauer, Bayona (bib0020) 2011; 38 An official ATS/IDSA statement (bib0010) 2007 Tan, Lai, Chou, Hsueh (bib0030) 2009; 13 Butler, O’Connor, Yakrus, Smithwick, Plikaytis, Moss (bib0005) 1993; 43 An official ATS/IDSA statement (10.1016/j.ijid.2014.02.020_bib0010) 2007 Butler (10.1016/j.ijid.2014.02.020_bib0005) 1993; 43 Tan (10.1016/j.ijid.2014.02.020_bib0030) 2009; 13 Ikegame (10.1016/j.ijid.2014.02.020_bib0035) 2012; 51 Jun (10.1016/j.ijid.2014.02.020_bib0040) 2010; 51 Falzon (10.1016/j.ijid.2014.02.020_bib0020) 2011; 38 Petrini (10.1016/j.ijid.2014.02.020_bib0045) 2006; 38 Christiansen (10.1016/j.ijid.2014.02.020_bib0025) 2004; 49 Piersimoni (10.1016/j.ijid.2014.02.020_bib0015) 1997; 24 |
| References_xml | – volume: 38 start-page: 516 year: 2011 end-page: 528 ident: bib0020 article-title: WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update publication-title: Eur Respir J – volume: 13 start-page: e459 year: 2009 end-page: e462 ident: bib0030 article-title: pulmonary infection mimicking pulmonary tuberculosis in a patient with ankylosing spondylitis publication-title: Int J Infect Dis – year: 2007 ident: bib0010 article-title: Diagnosis, treatment and prevention of nontuberculous mycobacterial diseases – volume: 51 start-page: 2203 year: 2012 end-page: 2207 ident: bib0035 article-title: Congenital cystic adenomatoid malformation in adulthood complicated by publication-title: Intern Med – volume: 51 start-page: 980 year: 2010 end-page: 983 ident: bib0040 article-title: Successful treatment of publication-title: Yonsei Med J – volume: 49 start-page: 19 year: 2004 end-page: 24 ident: bib0025 article-title: , an emerging pathogen and cause of false positive amplified publication-title: Diagn Microbiol Infect Dis – volume: 43 start-page: 539 year: 1993 end-page: 548 ident: bib0005 article-title: sp. nov publication-title: Int J Syst Bacteriol – volume: 24 start-page: 144 year: 1997 end-page: 147 ident: bib0015 article-title: Isolation of publication-title: Clin Infect Dis – volume: 38 start-page: 246 year: 2006 end-page: 255 ident: bib0045 article-title: Non-tuberculous mycobacterial infections publication-title: Scand J Infect Dis – volume: 38 start-page: 246 year: 2006 ident: 10.1016/j.ijid.2014.02.020_bib0045 article-title: Non-tuberculous mycobacterial infections publication-title: Scand J Infect Dis doi: 10.1080/00365540500444652 – year: 2007 ident: 10.1016/j.ijid.2014.02.020_bib0010 – volume: 38 start-page: 516 year: 2011 ident: 10.1016/j.ijid.2014.02.020_bib0020 article-title: WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update publication-title: Eur Respir J doi: 10.1183/09031936.00073611 – volume: 51 start-page: 2203 year: 2012 ident: 10.1016/j.ijid.2014.02.020_bib0035 article-title: Congenital cystic adenomatoid malformation in adulthood complicated by Mycobacterium celatum infection publication-title: Intern Med doi: 10.2169/internalmedicine.51.7848 – volume: 43 start-page: 539 year: 1993 ident: 10.1016/j.ijid.2014.02.020_bib0005 article-title: Mycobacterium celatum sp. nov publication-title: Int J Syst Bacteriol doi: 10.1099/00207713-43-3-539 – volume: 24 start-page: 144 year: 1997 ident: 10.1016/j.ijid.2014.02.020_bib0015 article-title: Isolation of Mycobacterium celatum from patients infected with human immunodeficiency virus publication-title: Clin Infect Dis doi: 10.1093/clinids/24.2.144 – volume: 51 start-page: 980 year: 2010 ident: 10.1016/j.ijid.2014.02.020_bib0040 article-title: Successful treatment of Mycobacterium celatum pulmonary disease in an immunocompetent patient using antimicobacterial chemotherapy and combined pulmonary resection publication-title: Yonsei Med J doi: 10.3349/ymj.2010.51.6.980 – volume: 49 start-page: 19 year: 2004 ident: 10.1016/j.ijid.2014.02.020_bib0025 article-title: Mycobacterium celatum, an emerging pathogen and cause of false positive amplified Mycobacterium tuberculosis direct test publication-title: Diagn Microbiol Infect Dis doi: 10.1016/j.diagmicrobio.2003.12.006 – volume: 13 start-page: e459 year: 2009 ident: 10.1016/j.ijid.2014.02.020_bib0030 article-title: Mycobacterium celatum pulmonary infection mimicking pulmonary tuberculosis in a patient with ankylosing spondylitis publication-title: Int J Infect Dis doi: 10.1016/j.ijid.2008.12.014 |
| SSID | ssj0004668 |
| Score | 2.0668218 |
| Snippet | Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the lungs and... Summary Mycobacterium celatum is a rare cause of human infection, causing disseminated disease in immunosuppressed individuals. Infections localized to the... |
| SourceID | doaj proquest pubmed crossref elsevier |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 88 |
| SubjectTerms | Aged Anti-Bacterial Agents - therapeutic use Azithromycin - therapeutic use Ciprofloxacin - therapeutic use Clarithromycin - therapeutic use Drug Therapy, Combination Ethambutol - therapeutic use Female Humans Infectious Disease Isoniazid - therapeutic use Lung - diagnostic imaging Lung - pathology Lung Diseases - diagnosis Lung Diseases - drug therapy Lung Diseases - microbiology Mycobacterium - drug effects Mycobacterium celatum Mycobacterium Infections - diagnosis Mycobacterium Infections - drug therapy Mycobacterium Infections - microbiology Non-tuberculous Mycobacterium Pulmonary/Respiratory Pyrazinamide - therapeutic use Radiography |
| SummonAdditionalLinks | – databaseName: ScienceDirect Freedom Collection 2013 dbid: .~1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9UwFD-MPYggovOrflHBN6m3aZKmedTpGML0QQd7C0mbjI673sv9eNiLf7vnNOllQ50gFErDSRNOz1eac34BeOulY84GqugJVSEq74pGq7IQ0mmrSl9hC2VbfK2PT8WXM3m2B4dTLQylVSbbH236aK1Tyyxxc7bs-9l3hr5LK1bREkFITYifQiiS8vc_2bXayFgOh8QFUafCmZjj1V_0hBbKxIjbSWd-X3NOI4b_DR_1txh09EVHD-B-CiLzD3GeD2HPDwdw5yRtkx_AvfgzLo81Ro_g2yfadaekF4wv85OrFpV4BGneXuYtZcPhPe3U5PRjNscZzBfDORIvt3MUVLu6yvsBLdmILr55DKdHn38cHhfpJIWilaraFOhy0KgF1tXSc6FVsLzl3nIrHS5JGt-UDvVUKh1CY1uGLBOccH60d5oH5fkT2B8Wg38GeRdYoxrmy1oTxnnQqPCisvgQeLC1z4BNLDRtghmn0y7mZsonuzDEdkNsN2WFV5nBu12fZQTZuJX6I32ZHSUBZI8Ni9W5SRJiXClYZyucusag1fMGp8hrr1TXtRzFMwM-fVcz1aCi1cQX9bcOrf7Uy6-T4q8NM2ukNL8JZwZy1_OGfP9zxDeT0BlUfNrNsYNfbHEkinwxfFY6g6dRGncswbiWgB7Z8_8c9QXcpaeYS_cS9jerrX-FwdfGvR616xdSpimD priority: 102 providerName: Elsevier |
| Title | Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1201971214014593 https://www.clinicalkey.es/playcontent/1-s2.0-S1201971214014593 https://dx.doi.org/10.1016/j.ijid.2014.02.020 https://www.ncbi.nlm.nih.gov/pubmed/25008771 https://www.proquest.com/docview/1561035279 https://doaj.org/article/b041da27e39045e382a936e77ddc3b1b |
| Volume | 26 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fa9UwFD7oHkQQcfNX1Y0Kvkm1aZKmeXRuYypTRAf3LSRtIndce8fuvQ978W_3nCYtE3R7EUoLJWnCyTk5X5pzvgC88tIxZwNl9ISqEJV3RaNVWQjptFWlr_ANRVt8ro9PxceZnF056otiwiI9cBTcW1cK1tlKeVycC-l5U1nNa69U17Uc26HZF33euJiaMiJjEhy6t0IrVqV0mRjZNT-bE0coEwNbJ530fcUlDcz9f3imfyHPwQMdPYD7CTrm72KXt-GW73fgzknaHN-Be_EXXB4zix7ClwPaa6dQF0SV-clli6Y7UDNvfuYtxcDhM-3P5PQ7NsceLJb9Dyx8vlmgetqLy3ze4_w1cIqvH8Hp0eH398dFOj-haKWq1gU6GpzKAutqlJvQKljecm-5lQ4XIo1vSofWKZUOobEtQ5EJTuw-2jvNA0r8MWz1y94_hbwLrFEN82Wtidk8aDRzgSPBRODB1j4DNorQtIlcnM64WJgxiuzMkNgNid2UFV5lBq-nOueRWuPa0vs0MlNJosUeXqCymKQs5iZlyYCP42rGzFOcK_FD82ubVn-r5VfJ3FeGmRWWNN9I30jdaNUqpOYZyKlmQjQRqdzY4stR6QyaO-3h2N4vN9gS4V0EzUpn8CRq4yQSRLNE78ie_Q9RPYe71KEYTvcCttYXG7-L-Gvt9uD2m19sbzA4vH-Y7eP909fmNykqLEA |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgESQlAoDc8gcUNh49iO4yMUqgW65UAr9WY5iV2l2mZX-zj0wm9nJnFWrYAiIUWK4oxjazKvxDOfAd46WbLSeqro8VkiMlcmhVZpImSprUpdhi2UbXGUj0_E11N5ugX7Qy0MpVUG29_b9M5ah5ZR4OZo3jSjHwx9l1Yso08EITW_BbcFqi9tY_D-J7tSHNnXwyF1QuShcqZP8mrOG4ILZaID7qRNv694pw7E_5qT-lsQ2jmjg4fwIESR8Yd-oo9gy7U7cGcS1sl34H7_Ny7ui4wew_dPtOxOWS8YYMaTywq1uENpXl_EFaXD4Tks1cT0ZzbGGUxn7RkSz9dTlFS7uIybFk1ZBy--egInB5-P98dJ2EohqaTKVgn6HLRqntW5dFxo5S2vuLPcyhK_SQpXpCUqqlTa-8JWDFkmOAH9aFdq7pXju7Ddzlq3B3HtWaEK5tJcE8i516jxIrN44bm3uYuADSw0VcAZp-0upmZIKDs3xHZDbDdphkcawbtNn3mPsnEj9Ud6MxtKQsjuGmaLMxNExJSpYLXNcOoao1aHcmE1z51SdV1xlM8I-PBezVCEimYTH9TcOLT6Uy-3DJq_NMwskdL8Jp0RyE3PawL-zxHfDEJnUPNpOce2brbGkSj0xfhZ6Qie9tK4YQkGtoT0yJ7956iv4e74eHJoDr8cfXsO9-hOn1j3ArZXi7V7iZHYqnzVadovNfAsnw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Disseminated+Mycobacterium+celatum+disease+with+prolonged+pulmonary+involvement&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Patsche%2C+Cecilie+Blenstrup&rft.au=Svensson%2C+Erik&rft.au=Wejse%2C+Christian&rft.date=2014-09-01&rft.pub=Elsevier+Ltd&rft.issn=1201-9712&rft.volume=26&rft.spage=88&rft.epage=90&rft_id=info:doi/10.1016%2Fj.ijid.2014.02.020&rft.externalDocID=S1201971214014593 |
| thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F12019712%2FS1201971214X0010X%2Fcov150h.gif |